Axelios 1 — Roche¶
Roche's nanopore "sequencing by expansion" (SBX) platform, pitched at a $150 / 30× duplex human genome.
At a glance¶
- Vendor / launch date / availability: Roche; revealed at AGBT 2026 (Marco Island, Feb 22–25); pre-orders open post-AGBT; formal commercial launch summer 2026 per GenomeWeb coverage dated Feb 2026.
- Chemistry / modality: Nanopore sequencing-by-expansion (SBX) — template DNA is enzymatically expanded into a longer, more discriminable polymer before nanopore readout.
- Throughput (PR): 16 human genomes per run per GenomeWeb / Roche AGBT release (vendor PR — no independent benchmark).
- Read length: Average duplex ~230–250 bp per GenomeWeb Feb 2026.
- Accuracy (PR): Q38 duplex per GenomeWeb Feb 2026 (vendor PR — no independent benchmark).
- List price / cost-per-genome: $750k instrument; $150 per 30× duplex genome; $0.06 per million reads simplex per GenomeWeb Feb 2026.
What's new vs prior generation¶
Axelios is Roche's first commercial sequencer since exiting 454 — a wholly new modality rather than an incremental upgrade. SBX expands template DNA into a longer reporter polymer that is then read on a nanopore, decoupling read accuracy from native base-by-base translocation speed and giving Roche a route to compete on cost-per-genome rather than read length.
Headline benchmarks¶
16 human genomes per run, average duplex 230–250 bp, Q38 duplex, $150 / 30× duplex genome (vendor PR — no independent benchmark) — GenomeWeb, Feb 2026.
omicsomics' run-pricing teardown (Mar 2026) argues the $150 headline is conditional on full-run utilization and that effective cost rises sharply at lower batch sizes.
Reception / competitive context¶
Roche entered AGBT 2026 as the most-watched re-entrant; the $150 genome anchors the lower bound of the AGBT 2026 short-read lineup alongside Element VITARI and Complete DNBSEQ-T7+ (both at $100/genome list). Vilella Part 2 flags the short duplex length (~230–250 bp) as the strategic weakness vs Element / Ultima / Complete on long-insert applications.
Cross-links¶
- Downstream Bioconductor tools: BSgenome, VariantAnnotation, methylKit for duplex methylation calling.
- Long-read alternative at AGBT 2026: PacBio CiFi (chromosome-scale HiFi assembly from one SMRT cell).
- Direct AGBT 2026 short-read competitors: Element VITARI, Complete DNBSEQ-T7+, Ultima UG200.